Abstract
This study was conducted to determine whether small doses of salbutamol solution, aerosolised and delivered by intermittent positive-pressure breathing (IPPB), would be as effective as the 5 to 10 mg dose usually recommended for inhalational use. In nine asthmatic subjects we found that there was no significant difference between the peak bronchodilator effect of 1.0, 2.5, and 5.0 mg of salbutamol solution as assessed by FEV1 (P greater than 0.05). The 5 mg dose of salbutamol solution caused a significantly longer duration of effect than the 1.0 mg and smaller doses of salbutamol, but it also caused four of the nine subjects to complain of unwanted effects. In addition, a radiotracer technique in four normal subjects showed that an inverse relationship exists between the amount of aerosol deposited in the lungs and the tidal folume of IPPB. The maximum dose deposited in the lungs was about 10% of that initially present in the nebuliser.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asmundsson T., Johnson R. F., Kilburn K. H., Goodrich J. K. Efficiency of nebulizers for depositing saline in human lung. Am Rev Respir Dis. 1973 Sep;108(3):506–512. doi: 10.1164/arrd.1973.108.3.506. [DOI] [PubMed] [Google Scholar]
- Choo-Kang Y. F., Grant I. W. Comparison of two methods of administering bronchodilator aerosol to asthmatic patients. Br Med J. 1975 Apr 19;2(5963):119–120. doi: 10.1136/bmj.2.5963.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choo-Kang Y. F., Parker S. S., Grant I. W. Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation. Br Med J. 1970 Nov 21;4(5733):465–468. doi: 10.1136/bmj.4.5733.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davies D. S. Pharmacokinetics of inhaled substances. Postgrad Med J. 1975;51(7 Suppl):69–75. [PubMed] [Google Scholar]
- Dolovich M. B., Killian D., Wolff R. K., Obminski G., Newhouse M. T. Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis. 1977 Mar;115(3):397–402. doi: 10.1164/arrd.1977.115.3.397. [DOI] [PubMed] [Google Scholar]
- Minette A. Ventilatory results and side-effects of salbutamol given by different routes in coalminers with reversible broncho-obstruction. Postgrad Med J. 1971 Mar;47(Suppl):55–61. [PubMed] [Google Scholar]
- Pavia D., Thomson M. L., Clarke S. W., Shannon H. S. Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax. 1977 Apr;32(2):194–197. doi: 10.1136/thx.32.2.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petty T. L. Editorial: A critical look at IPPB. Chest. 1974 Jul;66(1):1–3. doi: 10.1378/chest.66.1.1-a. [DOI] [PubMed] [Google Scholar]
- Ruffin R. E., Kenworthy M. C., Newhouse M. T. Response of asthmatic patients to fenoterol inhalation: a method of quantifying the airway bronchodilator dose. Clin Pharmacol Ther. 1978 Mar;23(3):338–345. doi: 10.1002/cpt1978233338. [DOI] [PubMed] [Google Scholar]
- Shenfield G. M., Evans M. E., Walker S. R., Paterson J. W. The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients. Am Rev Respir Dis. 1973 Sep;108(3):501–505. doi: 10.1164/arrd.1973.108.3.501. [DOI] [PubMed] [Google Scholar]
- Spitzer S. A., Goldschmidt Z., Dubrawsky C. The bronchodilator effect of salbutamol administered by IPPB to patients with asthma. A controlled comparison with isoproterenol and placebo. Chest. 1972 Sep;62(3):273–276. doi: 10.1378/chest.62.3.273. [DOI] [PubMed] [Google Scholar]